Consolidated Cash Flow Statement (unaudited)
|
Six months ended June 30 |
|
|---|---|---|
(thousands of €) |
2026 |
2025 |
Net profit/loss (–) of the period |
16,601 |
(259,151) |
|
|
|
Decrease (–)/increase in provisions |
(44,100) |
36,868 |
Adjustment for other non-cash transactions |
(84,749) |
131,337 |
Adjustment for items to disclose separately under operating cash flow |
(24,186) |
(22,743) |
Adjustment for items to disclose under investing and financing cash flows |
(6,484) |
(41,328) |
Change in working capital other than deferred income |
1,136 |
112,335 |
Cash used for other liabilities related to the acquisition of subsidiaries |
– |
(1,792) |
Decrease in deferred income |
– |
(117,286) |
|
|
|
Cash used in operations |
(141,782) |
(161,760) |
|
|
|
Interest paid |
(127) |
(304) |
Interest received |
25,855 |
14,880 |
Corporate taxes paid |
(787) |
(204) |
|
|
|
Net cash flow used in operating activities |
(116,841) |
(147,388) |
|
|
|
Purchase of property, plant and equipment |
(152) |
(9,250) |
Purchase of intangible fixed assets |
– |
(155) |
Proceeds from disposal of property, plant and equipment |
2,399 |
– |
Purchase of financial investments |
(902,036) |
(2,087,499) |
Investment income received related to financial investments |
52,555 |
42,338 |
Sale of financial investments |
1,740,650 |
2,201,540 |
Proceeds from settlement of hedging instrument |
– |
22,745 |
Cash in from the disposal of subsidiaries, net of cash disposed of |
4,112 |
9,733 |
Convertible loan issued to third party |
(62) |
(20,000) |
Acquisition of equity investments held at fair value through other comprehensive income |
(1,031) |
– |
Cash out from acquisition of subsidiaries, net of cash acquired |
(733,521) |
– |
|
|
|
Net cash flow generated from investing activities |
162,914 |
159,452 |
|
|
|
Payment of lease liabilities |
(1,578) |
(1,611) |
Purchase of own shares |
(2,870) |
– |
|
|
|
Net cash flow used in financing activities |
(4,448) |
(1,611) |
|
|
|
Increase in cash and cash equivalents |
41,625 |
10,453 |
|
|
|
|
|
|
Cash and cash equivalents at beginning of the period |
87,868 |
64,239 |
|
|
|
Increase in cash and cash equivalents |
41,625 |
10,453 |
Effect of exchange rate differences on cash and cash equivalents |
6,459 |
(3,023) |
|
|
|
Cash and cash equivalents at end of the period |
135,952 |
71,669 |
The accompanying notes form an integral part of these condensed consolidated financial statements.